Prosecution Insights
Last updated: November 04, 2026

Gmp Biotechnology Limited

Technology area: Biotechnology & Pharmaceuticals

2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready

Analysis

Gmp Biotechnology Limited has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 2 distinct examiners and 2 distinct art units.

POLIAKOVA-GEORGAN, EKATERINA is the busiest examiner, with 1 pending matter. Counsel should track the matters independently and review whether any prosecution issue recurs across the two assignments.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

2
Total Pending OAs
1
Non-Final OAs
1
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (50%)
1
Medium (50%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only1 (50%)
Multi-statute (no §101)1 (50%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

2
Life Sciences
100% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

20 h
Manual time on pending OAs
4 h
Time saved (low, 20%)
7 h
Time saved (mid, 35%)
0.2 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
POLIAKOVA-GEORGAN, EKATERINA 1 63.8% +18.3%
CAIN, JENNIFER LYNN 1 44.4% +68.4%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18518560 TGF-BETA THERAPEUTICS FOR AGE DISEASE POLIAKOVA-GEORGAN, EKATERINA —

Interview Candidates (2)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.

App #TitleExaminerDue in
17946578 TGF-BETA INHIBITION, AGENTS AND COMPOSITION THEREFOR CAIN, JENNIFER LYNN 8d overdue
18518560 TGF-BETA THERAPEUTICS FOR AGE DISEASE POLIAKOVA-GEORGAN, EKATERINA —

Top Art Units

Art UnitApps
1637 1
1655 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18518560 TGF-BETA THERAPEUTICS FOR AGE DISEASE POLIAKOVA-GEORGAN, EKATERINA 1637 §102§103§112Other Non-Final OA — Pending Nov 23, 2023
17946578 TGF-BETA INHIBITION, AGENTS AND COMPOSITION THEREFOR CAIN, JENNIFER LYNN 1655 §103 Final Rejection 8d overdue Pending Sep 16, 2022

Managing Gmp Biotechnology Limited's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Frequently Asked Questions

How many pending USPTO office actions does Gmp Biotechnology Limited have?

Gmp Biotechnology Limited has 2 pending office actions as of November 2026, spread across 2 art units and 2 examiners.

Which USPTO examiner handles the most Gmp Biotechnology Limited applications?

Ekaterina Poliakova-Georgan has the most, with 1 of Gmp Biotechnology Limited's pending office actions.

What technology area are Gmp Biotechnology Limited's patent applications in?

Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month